Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-Refractory Chronic GVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06233110
What this trial is testing

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Who this might be right for
Chronic Graft Versus Host Disease
Stefanie Sarantopoulos, MD, PhD. 30
Testing effectiveness (Phase 2)UnknownNCT00472225
What this trial is testing

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Steroid-Refractory Chronic GVHD
The Korean Society of Hematopoietic Stem Cell Transplantation 42
Early research (Phase 1)Study completedNCT01155817
What this trial is testing

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Who this might be right for
Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
Stanford University 33
Testing effectiveness (Phase 2)UnknownNCT01158105
What this trial is testing

Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)

Who this might be right for
Chronic Graft-versus-host Disease
Baylor Research Institute 25
Testing effectiveness (Phase 2)UnknownNCT02385019
What this trial is testing

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Graft vs Host Disease
Instituto de Medicina Molecular João Lobo Antunes 22
Not applicableEnded earlyNCT04852692
What this trial is testing

Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Who this might be right for
Chronic Graft vs Host Disease
Janssen Korea, Ltd., Korea 15
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Early research (Phase 1)Study completedNCT04987333
What this trial is testing

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Who this might be right for
Inflammatory Diseases
Amgen 32
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT01954979
What this trial is testing

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Beth Israel Deaconess Medical Center 56
Testing effectiveness (Phase 2)Looking for participantsNCT05327023
What this trial is testing

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Who this might be right for
Hematologic Neoplasms
National Cancer Institute (NCI) 430
Not applicableApproved For MarketingNCT05722912
What this trial is testing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT00388362
What this trial is testing

Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
Stanford University 36
Testing effectiveness (Phase 2)Ended earlyNCT01898377
What this trial is testing

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Who this might be right for
Chronic Graft-versus-host Disease
Seoul National University Hospital 9
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Early research (Phase 1)Temporarily pausedNCT05993611
What this trial is testing

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07476872
What this trial is testing

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Who this might be right for
cGVHDHSCT
Institute of Hematology & Blood Diseases Hospital, China 33
Large-scale testing (Phase 3)Study completedNCT03474679
What this trial is testing

The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Graft vs Host Disease
Janssen Pharmaceutical K.K. 19
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Next Page